MAPI Research Trust provides reliable, comprehensive and up-to-date information services to research scientists, pharmaceutical companies, and governmental health agencies involved in the fields of Patient-Reported Outcomes (PRO) and Pharmaco-Epidemiology worldwide.
Home SERVICES Questionnaire Licensing
SF-MPQ-2 (Short-form McGill Pain Questionnaire) PDF Print E-mail

Developed by:
Ronald Melzack and IMMPACT (Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials)

Objective:
To measure the major symptoms of both neuropathic and non-neuropathic pain that can be used in studies of epidemiology, natural history, pathophysiologic mechanisms, and treatment response

Copyright:
SF-MPQ-2 © R. Melzack and the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT), 2009. All Rights Reserved

Reference publication:
Dworkin RH, Turk DC, Revicki DA, Harding G, Coyne KS, Peirce-Sandner S, Bhagwat D, Everton D, Burke LB, Cowan P, Farrar JT, Hertz S, Max MB, Rappaport BA, Melzack R. Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2). Pain. 2009 Apr 6.


Conditions of use:

1. User-Agreement:
User is required to complete and sign a User Agreement in which specific conditions requested by the authors are detailed.

2. Access fees

carre6 Authors' royalty fees:

Authors' royalty fees are requested according to the study design and context of use of the questionnaire:

- In academic research and individual clinical practice: free of charge

- In commercial studies (1) involving "for-profit" organizations and academic studies funded by commercial companies: 2,000 Euros per protocol/application plus an administrative fee of 2 euros per each administration/ reproduction of the measure

Other specific conditions requested by the Authors are detailed in the User Agreement.


carre6 Distribution fees

Distribution fees are requested according to the study design and context of use of the questionnaire:

- In academic research and individual clinical practice: free of charge

- In commercial studies (1) involving "for-profit" organizations and academic studies funded by commercial companies: 1000 €* per study + 150 € per language version.


* excluding VAT

(1) Commercial studies (industry, CRO, any for-profit companies)


Review Copy:

English version available for review purpose only. Please click here to access.


New Translations:

For the production of new translations to be used in commercial studies, each translation shall be coordinated by Mapi Institute.


Contact information:

MAPI Research Trust
Christelle Berne

27 rue de la Villette
F - 69003 LYON
Tel: +33 4 72 13 65 75
Fax: +33 4 72 13 66 82
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Please have the User Agreement completed, dated and signed and return one original copy to MAPI Research Trust by post. As soon as we receive it, we will process your request.


More information on the SF-MPQ-2 on PROQOLID


[ BACK ]
 

New questionnaires distributed by MAPI Research Trust

ADCPQ (Alzheimer’s Disease Caregiver Preference Questionnaire)  
Novartis Pharmaceuticals Corporation (USA)

FIS (Fatigue Impact Scale)
D-FIS (Daily Fatigue Impact Scale)
John Fisk (Canada)  

HIV-SQUAD (Symptom Quality of Life Adherence) Questionnaire ®
Abbott France (France) 

MOS-HIV (Medical Outcome Study-HIV Health Survey)
Albert Wu (USA)

MPQ (McGill Pain Questionnaire)
Ronald Melzack (Canada)

MPQ-SF (McGill Pain Questionnaire - Short Form)
Ronald Melzack (Canada)

Nausea Questionnaire 
Ronald Melzack (Canada)

ODI (Oswestry Disability Questionnaire)
Jeremy Fairbank (UK)

PHQ (Patient Health Questionnaire Screeners
Pfizer Inc. (USA)

PRAC-Test (PRAgmatic Content and face validity Test)
Mapi Values (France)

SF-MPQ-2 (Short-form McGill Pain Questionnaire)
Ronald Melzack (Canada) and IMMPACT (USA) 


To access our catalog, please click here.



Coming soon!

Crohn and Anti-tnf Treatment Satisfaction questionnaire
Abbott France (France)


For any information, please contact:
contact@mapi-trust.org